VirekaLearning loop

What the desk is learning

Every rating makes Vireka sharper — and tells us what to build next.

Analyst feedback re-ranks each user's evidence (within confidence tiers) and, in aggregate, shows which signal types are trusted and exactly what data users are missing. This is the compounding asset — it can't be started cold. 5 ratings captured so far.

Signal-type trust
pricing
0▲ 2▼
access
1▲ 0▼
biosimilar
1▲ 0▼
market
0▲ 1▼
Data-gap backlog · what users are asking for
semaglutide“too generic”2026-07-17
semaglutide“need net price EU”2026-07-17
tirzepatide“need EU net price”2026-07-17

Aggregate, de-identified. ← Back to Vireka